Martire, G., Lovisa, F., Carraro, E., Rizzato, D., Cesaro, S., Mura, R. M., Tondo, A., Bertolin, C., Boaretto, F., Salviati, L., Biffi, A., Pillon, M. and Mussolin, L. (2020) “<i>TP53</i&gt; DNA binding domain mutational status and rituximabbased treatment are independent prognostic factors for pediatric Burkitt lymphoma patients stratification”, Haematologica. Pavia, Italy. doi: 10.3324/haematol.2023.284868.